Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled heparin for hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease
MOH_2021-09-19_010225Phase 2Not yet recruiting
- Sponsor
- פרופ' יונה נדיר
- Start
- Sep 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of heparin in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by פרופ' יונה נדיר. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on MOH_2021-09-19_010225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-09-19_010225.